BI 3032950

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for BI 3032950, covering 2024-11-21 to 2026-03-05. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis [Phase 2]